DRD2/ANKK1 rs1800497: What Your Genotype Means
The rs1800497 variant, historically known as the Taq1A polymorphism, is a genetic change located near the DRD2 gene. It is widely studied for its potential associations with dopamine receptor density in the brain and various behavioral and psychiatric traits.
What each genotype means
Typical dopamine receptor profile
This genotype represents the most common form of this variant. Research into this site has explored potential links to dopamine signaling and behavioral traits, but findings remain inconsistent across different studies and populations. This result does not provide a medical diagnosis or predict specific behavioral outcomes.
This is the most common genotype observed in most global populations.
Varied dopamine receptor profile
Carrying one copy of the T allele means you have a mix of the common and the less common variant at this position. Some research has investigated whether this variant influences dopamine receptor density or behavioral traits, but evidence is limited and often conflicting. You should not use this information to make health decisions or assume specific personality or behavioral traits.
This genotype is found in a significant portion of the population, with frequencies varying by ancestry.
Distinct dopamine receptor profile
This genotype is the less common variant at this position. Some studies have explored associations between this genotype and various behavioral or neurodevelopmental traits, but these findings are not consistently replicated and remain a subject of ongoing scientific debate. This information is for educational purposes and does not indicate a clinical condition.
This genotype is less common than the C/C or C/T genotypes, with a minor allele frequency typically ranging between 0.10 and 0.20 in many cohorts.
Understanding the Variant and Its Location
The rs1800497 variant is a single nucleotide polymorphism (SNP) that has been extensively investigated in neuroscience and genetics. While it is frequently referred to as a DRD2 variant, it is actually located approximately 10,000 base pairs downstream of the DRD2 gene, specifically within the eighth exon of the neighboring ANKK1 gene. Because of its proximity to the dopamine D2 receptor gene, researchers have long hypothesized that it influences the expression or function of the D2 receptor. Historically, this site was identified using the TaqI restriction enzyme, leading to its common name, Taq1A. The two primary alleles are often referred to as A1 and A2 in scientific literature, corresponding to the specific nucleotide changes at this position. Understanding that this variant sits in a regulatory or linked region rather than directly inside the DRD2 coding sequence is crucial for interpreting how it might influence brain chemistry.
The Role of the DRD2 Gene
The DRD2 gene provides instructions for making the dopamine D2 receptor, a protein that plays a central role in the brain's reward system and motor control. Dopamine is a neurotransmitter that acts as a chemical messenger, and the D2 receptor is essential for transmitting these signals across synapses. By modulating dopamine signaling, the D2 receptor influences processes such as motivation, learning, memory, and the regulation of movement. Because the reward pathway is involved in reinforcing behaviors, variations in the genes that control this system are often studied in the context of substance use, addiction, and psychiatric conditions. While rs1800497 is located in the ANKK1 gene, it is in linkage disequilibrium with other functional variants in the DRD2 region, meaning it is often inherited alongside them. This genetic linkage is why researchers continue to study this specific SNP to understand how it might correlate with differences in receptor density and overall dopaminergic function.
Research Associations and Evidence Strength
Research into rs1800497 has produced a vast but complex body of literature. Many studies have suggested that the A1 allele is associated with lower density and reduced binding of D2 receptors in the striatum, a brain region critical for reward processing. Consequently, this variant has been investigated for associations with conditions like alcoholism, smoking behavior, and schizophrenia. However, the evidence is considered limited and often inconsistent. While some meta-analyses show small, statistically significant associations with specific behaviors, other studies fail to replicate these findings. The complexity arises because behavioral traits are polygenic, meaning they are influenced by hundreds of genetic variants and environmental factors, not just one SNP. Furthermore, the functional mechanism remains a subject of debate, as the variant's location in ANKK1 suggests it may influence dopamine signaling through indirect pathways. Because of these mixed results, this variant should not be used to predict individual outcomes or diagnose any medical condition.
Population Frequency
The frequency of the rs1800497 alleles varies significantly across different global populations. The minor allele frequency generally ranges from approximately 0.06 to 0.41, depending on the ancestral cohort studied. Higher frequencies of the C allele (often associated with the A2 genotype) are commonly observed in European, Australian, and African populations, while the distribution of the A1 allele shows distinct patterns across East Asian and North American cohorts. These variations highlight the importance of considering ancestry when interpreting genetic data, as the prevalence of specific genotypes is not uniform worldwide.
Interpreting Your Genetic Information
If you have received information about your rs1800497 genotype, it is important to view it within the context of current scientific understanding. This variant is a tool for population-level research rather than a diagnostic marker for individuals. Because the associations with behavioral traits are small and inconsistent, knowing your genotype does not provide a clear prediction of your health or personality. You cannot use this information to determine your risk for addiction or psychiatric disorders. If you are concerned about how your genetics might influence your response to medications—such as antipsychotics, which target dopamine receptors—you should discuss this with your physician or a qualified pharmacist. They can provide guidance based on your clinical history and current medical standards. Genetic information is only one piece of a much larger puzzle that includes your environment, lifestyle, and overall health history.
How common is this variant?
The minor allele frequency for rs1800497 ranges from approximately 6% to 41% across different global populations, with significant variation observed between European, African, and East Asian cohorts.
Frequently asked questions
Is rs1800497 a diagnostic test for addiction?
No. The rs1800497 variant is not a diagnostic test for addiction or any other medical condition. While it has been studied in the context of reward pathways, the evidence is not strong enough to use it for individual clinical diagnosis.
Does the A1 allele mean I have low dopamine?
Not necessarily. While some research suggests the A1 allele is linked to lower D2 receptor density, this does not equate to a simple 'low dopamine' state. Brain chemistry is highly complex and regulated by many different genes and environmental factors.
Should I change my medication based on this SNP?
You should never change your medication based on genetic information without consulting your doctor. Always discuss any concerns about medication response or side effects with your healthcare provider or pharmacist.
Why is this variant called both DRD2 and ANKK1?
The variant is located in the ANKK1 gene, which sits right next to the DRD2 gene. Because it was historically linked to DRD2 function, it is often referred to as a DRD2 variant, even though it is technically inside the ANKK1 gene.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800498?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This SNP in the DRD2 gene is frequently studied in the context of psychiatric genetics, particularly regarding dopamine receptor expression and schizophrenia risk.
This variant has been studied for its association with schizophrenia and dopaminergic signaling.
The TaqIB polymorphism in the DRD2 gene is associated with dopamine receptor density and various behavioral and reward-related traits.
The DRD2 TaqIB variant modulates dopamine D2 receptor density and has been investigated for associations with addiction susceptibility and antipsychotic response.
A synonymous coding variant in exon 7 of DRD2 that affects mRNA stability, translation kinetics, and dopamine-related working memory and reward phenotypes.
A rare variant identified in the DRD2 gene, which is involved in the regulation of stress-induced behavioral responses.